Fate’s management team has the passion and experience to explore new biology, develop innovative therapeutics, create formidable intellectual property, launch new business models and foster high-value strategic collaborations.

Scott Wolchko
Scott Wolchko
President & CEO
Dan Shoemaker
Dan Shoemaker, Ph.D.
Chief Scientific Officer
Bob Valamehr
Bob Valamehr, Ph.D.
Chief Development Officer
3bio goes here
Cindy Tahl
Cindy Tahl, J.D.
General Counsel
Jim Beitel
Jim Beitel
Senior Vice President, Corporate Development
Sarah Cooley, M.D., M.S.
Senior Vice President, Clinical Translation
6bio goes here
Wen Bo Wang
Wen Bo Wang
Senior Vice President, Technical Operations
Yu-Waye (Wayne) Chu, M.D.
Senior Vice President, Clinical Development
9bio goes here9